Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Luteolin: A promising natural agent in management of pain in chronic conditions
Foteini Ntalouka, Athina Tsirivakou
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 37
Recent advancements in deciphering the therapeutic properties of plant secondary metabolites: phenolics, terpenes, and alkaloids
Bisma Hilal, Mohammad Mansoob Khan, Qazi Fariduddin
Plant Physiology and Biochemistry (2024) Vol. 211, pp. 108674-108674
Closed Access | Times Cited: 18
Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease
Tarun Minocha, Hareram Birla, Ahmad A. Obaid, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 59
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
Heba A. S. El‐Nashar, Haidy Abbas, Mariam Zewail, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1202-1202
Open Access | Times Cited: 46
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Potential innovation against Alzheimer’s disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery
Chenmala Karthika, Anoop Pattanoor Appu, Rokeya Akter, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 8, pp. 10950-10965
Closed Access | Times Cited: 35
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids
Leila Kooshki, Seyede Nazanin Zarneshan, Sajad Fakhri, et al.
Phytomedicine (2023) Vol. 112, pp. 154686-154686
Closed Access | Times Cited: 29
Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments
Tianyue Wang, Yuanjun Yin, Xinyu Jiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype
Heng Yuan, Xuangao Wu, Xichun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2183-2183
Open Access | Times Cited: 10
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease
Lorenza Guarnieri, Francesca Bosco, Antonio Leo, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102210-102210
Open Access | Times Cited: 8
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 8
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 7
Bioinformatics and Deep Learning Approach to Discover Food-Derived Active Ingredients for Alzheimer’s Disease Therapy
Junyu Zhou, Chen Li, Y. KIM, et al.
Foods (2025) Vol. 14, Iss. 1, pp. 127-127
Open Access
Methyl Derivatives of Flavone as Potential Anti-Inflammatory Compounds
Dagmara Jaworska, Małgorzata Kłósek, Joanna Bronikowska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 729-729
Open Access
Dietary Polyphenols to Combat Nonalcoholic Fatty Liver Disease via the Gut–Brain–Liver Axis: A Review of Possible Mechanisms
Zhenyu Wang, Maomao Zeng, Zhaojun Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 12, pp. 3585-3600
Closed Access | Times Cited: 40
Flavonoids from Seabuckthorn (Hippophae rhamnoides L.) restore CUMS-induced depressive disorder and regulate the gut microbiota in mice
Chen-Xi Xia, Alex Xiong Gao, Yue Zhu, et al.
Food & Function (2023) Vol. 14, Iss. 16, pp. 7426-7438
Closed Access | Times Cited: 17
Potential Anti-Cholinesterase Activity of Bioactive Compounds Extracted from Cassia grandis L.f. and Cassia timoriensis DC.
Maram B. Alhawarri, Roza Dianita, Mira Syahfriena Amir Rawa, et al.
Plants (2023) Vol. 12, Iss. 2, pp. 344-344
Open Access | Times Cited: 15
Natural products as potential modulators of pro-inflammatory cytokines signalling in Alzheimer's disease
Vikas Yadav, C Mythri, Murali Kumarasamy
Brain Behavior and Immunity Integrative (2024) Vol. 5, pp. 100048-100048
Open Access | Times Cited: 5
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 4
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 4
Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols
Meng Zhang, Guanhua Hu, Nan Shao, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1317-1329
Closed Access | Times Cited: 33
Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer’s Disease: A Review
Hui Xu, Qian Zhou, Bin Liu, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 39, pp. 11554-11571
Closed Access | Times Cited: 32
Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer’s Disease: Focus on Polyphenols and Dietary Fibers
Andrea Ticinesi, Leonardo Mancabelli, Luca Carnevali, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 961-982
Closed Access | Times Cited: 24
Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System
Sunmin Park, Xuangao Wu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13574-13574
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top